132 related articles for article (PubMed ID: 9208106)
1. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
[TBL] [Abstract][Full Text] [Related]
3. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
[TBL] [Abstract][Full Text] [Related]
4. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
6. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
[TBL] [Abstract][Full Text] [Related]
7. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
[TBL] [Abstract][Full Text] [Related]
8. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
[TBL] [Abstract][Full Text] [Related]
9. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
[TBL] [Abstract][Full Text] [Related]
11. Essential fatty acids are antagonists of the leukotriene B4 receptor.
Yagaloff KA; Franco L; Simko B; Burghardt B
Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):293-7. PubMed ID: 7630916
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of structural analogues of leukotriene B4 and their receptor binding activity.
Konno M; Nakae T; Sakuyama S; Nishizaki M; Odagaki Y; Nakai H; Hamanaka N
Bioorg Med Chem; 1997 Aug; 5(8):1621-47. PubMed ID: 9313867
[TBL] [Abstract][Full Text] [Related]
13. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
Jackson RH; Morrissey MM; Sills MA; Jarvis MF
J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues.
Boehm JC; Gleason JG; Pendrak I; Sarau HM; Schmidt DB; Foley JJ; Kingsbury WD
J Med Chem; 1993 Oct; 36(22):3333-40. PubMed ID: 8230123
[TBL] [Abstract][Full Text] [Related]
17. 15-Acetylthioxy-furodysinin lactone, isolated from a marine sponge Dysidea, sp. is a potent agonist to human leukotriene B4 receptor.
Mong S; Votta B; Sarau HM; Foley JJ; Schmidt D; Carte BK; Poehland B; Westley J
Prostaglandins; 1990 Jan; 39(1):89-97. PubMed ID: 2155439
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
[TBL] [Abstract][Full Text] [Related]
19. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
20. Trisubstituted benzene leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Konno M; Nakae T; Sakuyama S; Odagaki Y; Nakai H; Hamanaka N
Bioorg Med Chem; 1997 Aug; 5(8):1649-74. PubMed ID: 9313868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
